What is Arbutus Biopharma Corporation's capex?

Arbutus Biopharma Corporation (ABUS) reported capex of $0 in Q4 2025.

How has Arbutus Biopharma Corporation's capex changed year-over-year?

Arbutus Biopharma Corporation's capex decreased by 100.0% year-over-year, from $86K to $0.

What is the long-term trend for Arbutus Biopharma Corporation's capex?

Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's capex has grown at a -100.0% compound annual growth rate (CAGR), from $809K to $0.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Arbutus Biopharma Corporation ABUS CapEx

Discontinued — last reported Q4 '25

CapEx at other companies

Arrowhead ResearchARWR

$2.57M-51.6%

Gilead SciencesGILD

$117M+12.5%

ALN

Alnylam PharmaceuticalsALNY

$21.83M+143%

AnaptysBio, Inc.ANAB

$17K-51.4%

Vir Biotechnology, Inc.VIR

$390K-76.1%

AbCellera Biologics Inc.ABCL

$3.83M-64.0%

Other financials

Income statement

See full

Revenue$179.1M+10,055%

Operating income$168.9M+757%

Net income$169.7M+792%

EPS (diluted)$0.87+769%

Balance sheet

See full

Cash & equivalents$23.7M-36.1%

Total debt$631.0K-46.9%

Total equity$260.2M+229%

Total assets$277.2M+137%

Cash flow

See full

Operating cash flow-$8.1M+39.4%

Free cash flow-$4.7M+55.0%

Valuation

See full

Market cap$881.02M+34.1%

Enterprise value$857.94M+38.1%

P/E5.5×—

P/S4.6×-98.0×

Profitability

See full

Operating margin81.7%+42.1pp

Net margin84%+43.4pp

FCF margin-281.5%-119pp

Returns & leverage

See full

Return on equity94.7%+65.1pp

Debt / equity0×0.0×

Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Arbutus Biopharma Corporation’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arbutus Biopharma Corporation's capex?: Arbutus Biopharma Corporation (ABUS) reported capex of $0 in Q4 2025.
How has Arbutus Biopharma Corporation's capex changed year-over-year?: Arbutus Biopharma Corporation's capex decreased by 100.0% year-over-year, from $86K to $0.
What is the long-term trend for Arbutus Biopharma Corporation's capex?: Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's capex has grown at a -100.0% compound annual growth rate (CAGR), from $809K to $0.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.